To establish the prevalence of insulin resistance and impaired glucose tolerance (IGT) and their determinants in a cohort of obese children and adolescents. METHODS: A retrospective design was used. The study group included 234 patients with a body mass index (BMI) greater than the 95th percentile for age and gender and 22 patients with a BMI between the 85th and 95th percentile for age and gender referred for evaluation to a major tertiary-care center in Israel. Ages ranged from 5 to 22 y. Estimates of insulin resistance (homeostatic model assessment (HOMA-IR)); insulin sensitivity (ratio of fasting glucose (GF) to fasting insulin (IF) (GF/IF), the quantitative insulin sensitivity check index (QUICKI)), and pancreatic b-cell function (HOMA-derived b-cell function (HOMA %B)) were derived from fasting measurements. An oral glucose tolerance test (OGTT) was performed in 192 patients to determine the presence of IGT. RESULTS: Insulin resistance was detected in 81.2% of the patients, IGT in 13.5%, and silent diabetes in one adolescent girl. Only two patients with IGT also had impaired fasting glucose (IFG). The prevalence of IGT was higher in adolescents than prepubertal children (14.7 vs 8.6%). GF/IF and QUICKI decreased significantly during puberty (Po0.005), whereas HOMA-IR and HOMA %B did not. Insulin resistance and insulin sensitivity indexes were not associated with ethnicity, presence of acanthosis nigricans or family history of type 2 diabetes. Patients with obesity complications had lower insulin sensitivity indexes than those without (P ¼ 0.05). Compared with subjects with normal glucose tolerance (NGT), patients with IGT had significantly higher fasting blood glucose (85.976.5 vs 89.2710.6 mg/dl, Po0.05), higher 2-h post-OGGT insulin levels (101.2774.0 vs 207.67129.7 mU/ml, Po0.001), a lower QUICKI (0.32370.031 vs 0.30970.022, Po0.05), and higher fasting triglyceride levels (117.4753.1 vs 156.9768.9, P ¼ 0.002). However, several of the fasting indexes except QUICKI failed to predict IGT. There was no difference between the group with IGT and the group with NGT in fasting insulin, HOMA-IR, HOMA %B or the male-to-female ratio, age, BMI-SDS, presence of acanthosis nigricans, ethnicity, and family history of type 2 diabetes. CONCLUSIONS: Insulin resistance is highly prevalent in obese children and adolescents. The onset of IGT is associated with the development of severe hyperinsulinemia as there are no predictive cutpoint values of insulin resistance or insulin sensitivity indexes for IGT, and neither fasting blood glucose nor insulin levels nor HOMA-IR or HOMA %B are effective screening tools; an OGTT is required in all subjects at high risk. Longitudinal studies are needed to identify the metabolic precursors and the natural history of the development of type 2 diabetes in these patients.
Introduction
Fueled by changes in food consumption and health habits that have evolved over the last three decades, the prevalence of obesity in children and adolescents has reached epidemic proportions in both developed and developing countries. [1] [2] [3] This has led to a striking worldwide increase in the rate of type 2 diabetes mellitus in this age group. [4] [5] [6] Obesity leads to insulin resistance and increased circulating insulin concentrations over time, thereby decreasing insulin sensitivity and impairing pancreatic b-cell functionFthe two main components in the pathogenesis of type 2 diabetes. The disease emerges when blood glucose becomes uncontrolled. 7, 8 Studies in adults have shown that type 2 diabetes develops over a long period, and most patients initially have impaired glucose tolerance (IGT), which is an intermediate stage in the natural history of type 2 diabetes 9 and predicts the risk of the development of diabetes 10 and cardiovascular disease. 11 In children and adolescents, however, although severe obesity plays a prominent pathogenetic role in type 2 diabetes, whether it is a risk factor for IGT in this population, remains unclear. Several recent studies demonstrated that IGT too has become a major concern in obese children and adolescents, 12, 13 but information on the factors that contribute to this clinical problem is lacking. The aim of this retrospective study was to establish the prevalence of insulin resistance and IGT and their determinants in a large cohort of obese children and adolescents. We also examined the association between the presence of insulin resistance and other complications of obesity.
Patients and methods
The study population consisted of 256 patients, 109 boys and 147 girls aged 5-22 y who were referred to the Pediatric Obesity Clinic at Schneider Children's Medical Center of Israel, a tertiary-care center, between 1997 and 2003.
A detailed medical and family history was obtained for all subjects, including parental anthropometric measurements, family history of type 2 diabetes or maternal history of gestational diabetes, presence of polycystic ovary syndrome (PCO) in girls, and presence of complications secondary to obesity (hypertension, fatty liver, sleep apnea, respiratory problems, pseudotumor cerebri). None of the patients was taking any medication at the time of evaluation for the presence of insulin resistance and IGT.
Physical examination included measurements of height (with a Harpenden-Holtain stadiometer) and weight, evaluation for the presence of acanthosis nigricans, and assessment of pubertal stage (on the basis of breast development in girls and testicular volume in boys), according to the criteria of Marshall and Tanner. 14, 15 All subjects had normal thyroid function. Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared. Children with BMI values greater than the 95th percentile for age and gender were classified as 'overweight', 16 and those with a BMI between the 85th and 95th percentiles for age and gender were classified as 'at risk for overweight'. 16 To compare BMI values across different ages and by gender, the BMI SDS was calculated. After a 10-h overnight fast, blood samples were obtained for laboratory evaluation of fasting glucose and insulin, triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol.
A standard (1.75 g/kg body weight (up to 75 g)) oral glucose tolerance test (OGTT) was performed in 192 patients (75%) who met the following criteria: family history of type 2 diabetes in a first-or second-degree relative or clinical signs of insulin resistance (acanthosis nigricans or polycystic ovary syndrome). The test was performed in the morning, after a 10-h overnight fast. Blood samples for measurements of plasma glucose and insulin were obtained at baseline (fasting) and every 30 min for 120 min after an oral glucose load.
Impaired fasting glucose (IFG) was defined, in accordance with the American Diabetes Association guidelines, as a fasting plasma glucose level of 100-125 mg/dl, and IGT was defined as a 2-h post-OGTT plasma glucose level of 140-199 mg/dl; type 2 diabetes was defined as a fasting glucose level of 126 mg/dl or higher or a 2-h plasma glucose level of more than 200 mg/dl. 17 The gold standard methods for measuring insulin sensitivity and pancreatic b-cell function are the hyperinsulinemic-euglycemic clamp and hyperglycemic clamp, respectively. 18 However, because these procedures are in- For the biochemical study, serum glucose was measured by the glucose oxidase colorimetric method using an automated analyzer (Hitachi 917, Roche Diagnostics, Mannheim, Germany), and total cholesterol, triglycerides, and HDLcholesterol concentrations were measured by an enzymatic colorimetric method on an automated analyzer (Hitachi 904, Roche Diagnostics). Serum insulin concentrations were measured by an immunometric assay with the IMMULITE 2000 Analyzer (DPC, Los Angeles, CA, USA). HbA1C levels were measured by the turbidimetric inhibition immunoassay (Hitachi 911, Roche Diagnostics) (normal range: 4.3-5.8%).
Statistical analysis
The data were analyzed using BMDP software. 24 Pearson's w 2 test or Fisher's exact test was used for analysis of differences in discrete variables, as appropriate and analysis of variance (ANOVA) was used for continuous variables. Correlations between continuous variables were analyzed with Pearson's correlation. A P-value of r0.05 was considered significant.
Insulin resistance in obese children and adolescents S Shalitin et al Table 1 provides the clinical and demographic characteristics of the patients, and Table 2 provides the anthropometric and laboratory data. A total of 234 subjects (91%) had a BMI greater than 95th percentile for age and gender and were classified as 'overweight'; the remainder (9%) had a BMI between the 85th and 95th percentile for age and gender and were classified as 'atrisk for overweight'. Acanthosis nigricans was found in 145 patients (56.6%); and a family history of type 2 diabetes or maternal gestational diabetes was documented in 145 patients (56.6%). Health-related complications of obesity were found in 147 patients (57.4%). Fatty liver was confirmed in 10 patients (3.9%) by the presence of persistently elevated levels of aspartate aminotransferase (AST) (440 U/l) and alanine aminotransferase (ALT) (440 U/ l) in association with ultrasound findings of an echogenic liver and exclusion of other causes of chronic hepatitis. Pseudotumor cerebri was confirmed in five patients (1.9%) by funduscopic evaluation and brain computerized tomography. Hypertension, defined as elevated systolic or diastolic blood pressure exceeding the 95th percentile adjusted for age and gender, 25 was found in 18 patients (7%), and a history of sleep apnea in 16 (6.3%). There were no significant differences between boys and girls for any of these factors.
Results

Patient characteristics
Of the 128 adolescent girls, 42 (32.8%) had hirsutism, acne, irregular menses, increased levels of ovarian androgens, and an LH/FSH ratio of 3:1 or more suggesting the diagnosis of PCO.
PCO group characteristics
Mean age of the 42 girls with PCO was 16.872. 3 y, and mean BMI-SDS was 3.2171.37. In all, 28 patients in this group (67.6%) had acanthosis nigricans and 22 (51.6%) had a family history of type 2 diabetes or maternal gestational diabetes.
Insulin resistance A total of 208 patients (81.2%) had insulin resistance, as defined by a HOMA-IR of 42, based mainly on adult reference standards. There was no difference for this factor by gender. The prevalence of insulin resistance was significantly higher in the patients in Tanner stages IV-V and II-III than in Tanner stage I (88.7 and 82.1%, respectively vs 63.2%, Po0.005), for both genders. The HOMA-IR index did not show a significant increase during puberty. Accordingly, the subjects with insulin resistance were significantly older (13.973.4 vs 11.673.3 y, Po0.001) than those with HOMA-IR r2, and they had a significantly higher BMI-SDS (3.4371.41 vs 2.8971.26, Po0.05) and significantly higher blood glucose (115.4726.3 vs 105.6724.6 mg/dl, Po0.05) and insulin levels (127.5792.8 vs 66.3762.6 mU/ml, Po0.001) after OGTT. We did not find a significant difference in HOMA-IR between the adolescent girls with and without PCO. (Figure 2 ). There was a significant correlation between GF/IF ratio and BMI (R ¼ Insulin resistance in obese children and adolescents S Shalitin et al family history of type 2 diabetes, and parental obesity were similar in the two groups. All the patients with fatty liver, pseudotumor cerebri, or sleep apnea had a HOMA-IR 42, as did 94% of the girls with PCO.
B-cell function
There was a low, albeit significant, correlation between HOMA-B% and BMI (R ¼ 0.186, Po0.005). HOMA-B% did not show a significant variation during puberty. We did not find an association between HOMA-B% and family history of type 2 diabetes.
Impaired glucose tolerance
In all, 26 patients (13.5%) had IGT. Silent diabetes was diagnosed in one adolescent girl (0.5%). Only two patients with IGT also had IFG. The prevalence of IGT was higher in adolescents than prepubertal children (14.7 vs 8.6%), but the difference was not statistically significant. The prevalence of IGT among the adolescents with PCO was 16.1%.
Compared with subjects with normal glucose tolerance (NGT), patients with IGT had significantly higher fasting blood glucose (85.976.5 vs 89.2710.6 mg/dl, Po0.05), higher 2-h post-OGTT insulin levels (101.2774.0 vs 207.67129.7 mU/ml, Po0.001), a lower QUICKI index (0.32370.031 vs 0.30970.022, Po0.05), and higher fasting triglyceride levels (117.4753.1 vs 156.9768.9, P ¼ 0.002) ( Table 3 ). However, there was no difference between these groups in fasting insulin, HOMA-IR or HOMA-%B indexes, or in male-to-female ratio, age, BMI-SDS, presence of acanthosis nigricans, ethnicity, and family history of type 2 diabetes.
Our attempts to demonstrate the efficacy of insulin resistance or insulin sensitivity measures in screening for IGT failed to yield predictive cutpoint values. The sensitivity and specificity of a HOMA-IR cutpoint value of 2 to predict the presence of IGT were 96.2 and 16.9%, respectively; corresponding values for a QUICK1 cutpoint of 0.339 were 84.6 and 32.7%.
There was no significant difference between the group of patients who underwent the OGTT and those who did not in HOMA-IR, QUICKI, GF/IF or HOMA %B indexes, HbA1c, or lipid profile.
Cardiovascular risk factors
Abnormalities in fasting lipid levels were adjusted for age and gender. 26 
Discussion
Decreased insulin sensitivity and impaired pancreatic b-cell function are the two main pathogenetic components of type 2 diabetes. In our cohort of obese children and adolescents, we found a high prevalence of insulin resistance, demonstrated by HOMA-IR or QUICKI. IGT was present in 13.5% of the patients. Our results indicate that the factors associated with IGT were elevated fasting glucose, hyperinsulinemia after glucose challenge and a lower QUICKI index. These data suggest that the onset of IGT in young obese subjects is associated with the development of severe hyperinsulinemic response to OGTT due to decreased insulin sensitivity, but relative insulin deficiency in the fasting state. However, we could not find a cutpoint value of HOMA-IR or QUICKI that could predict the presence of IGT. Although it is accepted that HOMA-IR and QUICKI are highly correlated, we did not find a significant difference in HOMA-IR between the group with IGT and the group with NGT. This may be explained by the finding that HOMA-IR does not vary linearly across wide ranges of insulin sensitivity, and QUICKI may be therefore a more accurate index of insulin sensitivity. Accordingly, Katz et al 22 reported a closer fit for the QUICKI than the HOMA-IR to results for the glucose clamp. The QUICKI correlated with metabolic manifestations of insulin resistance and was able to Insulin resistance in obese children and adolescents S Shalitin et al discriminate increases in insulin resistance among diabetic patients, patients with IGT, and healthy persons. 27 IGF was found in only two of our patients with IGT, suggesting that fasting hyperglycemia is indicative of a more advanced stage of impaired glucose metabolism. Thus, neither fasting blood glucose nor insulin resistance indexes served as effective screening tools. It may be the ability of bcells to compensate for the degree of insulin resistance that contributes to the failure in glucose regulation. However, we did not find a significant difference in the HOMA-%B index (estimate of pancreatic b-cell function) between the NGT and IGT groups. These data may indicate that IGT is associated with relatively preserved b-cell function, and only in the presence of established diabetes does b-cell failure become fully manifest.
Alternatively, there may be other genetic and metabolic factors that are present in a part of the population and contribute to IGT and to progressive b-cell dysfunction.
The 13.5% prevalence of IGT in our patients is higher than the 4.4% reported in European countries, 28 but lower than reported in studies from America. 12, 29 Sinha et al 12 found a 25% prevalence of IGT in children and 21% in adolescents, and a prevalence of 4% for type 2 diabetes. Rates were higher in Hispanic (23%) and non-Hispanic black subjects (33%) than in non-Hispanic white subjects (19.6%). Goran et al 29 reported a higher prevalence of 28% in obese adolescents. This difference may have been due to racial or lifestyle differences between the samples. There were no differences in the prevalence of IGT or abnormal HOMA-IR or QUICKI in our Israeli sample by ethnic origin. This may indicate that the ethnic difference in insulin resistance is limited to Caucasians and other races. The Bogalusa Heart Study was the first to show evidence of increased insulin resistance in African-American children compared with Caucasian children, based on measures of fasting insulin. 30 Goran et al 31 compared Caucasian, AfricanAmerican, and Hispanic children, and showed that Hispanic children are more insulin resistant than Caucasian children, independent of adiposity. Some of the factors that have been suggested to contribute to the development of IGT and type 2 diabetes in the young population include positive family history of type 2 diabetes, insulin resistance exacerbated by transient pubertal insulin resistance, and greater adiposity, especially visceral fat.
Since type 2 diabetes has a strong genetic and familial component, a positive parental history is used as a surrogate measure of risk. 32 Srinivasan et al 33 reported that offspring of parents with type 2 diabetes had a higher rate of adverse risk profiles of insulin resistance from childhood to young adulthood. In our study, however, a positive family history of type 2 diabetes, even in a first-degree relative, had no significant effect on the presence of IGT or insulin resistance. Others have reported similar findings. 12, 34 Pubertal insulin resistance has been well documented in several cross-sectional studies. 8, 35 Pubertal development is associated with an approximately 25-30% reduction in insulin sensitivity, with a peak reduction at Tanner stage III, followed by recovery by Tanner stage V. 8 This drop may be driven by the transient increase in growth hormone levels during puberty. Growth hormone may also contribute to insulin resistance via its effect on increasing lipolysis and free fatty acid concentrations. 36 In our cohort, the prevalence of insulin resistance, reflected by abnormal HOMA-IR or QUICKI values increased during the transition from Tanner I to IV-V, with the highest prevalence at Tanner IV-V. The effects of the increase in BMI associated with the progression of puberty, and the decrease in insulin sensitivity in late puberty, were supported by the significant association found in our study between BMI-SDS and insulin sensitivity indexes. Similar results were noted by Sinaiko et al. 37 By contrast with Sinha et al, 12 we did not detect a difference in BMI between the IGT and NGT groups, suggesting that obesity per se may not be the critical factor. This finding might also be explained by the fact that the majority of our patients were severely obese. Acanthosis nigricans is a dermatological abnormality. In children and adolescents, it has been described almost exclusively in association with insulin-resistant states, and it is considered to be a marker of such states. 38 However, in the present study, although 56.6% of the obese subjects had acanthosis nigricans, it was not a reliable marker for the presence of IGT or for abnormal HOMA-IR or QUICKI values. Nguyen et al 39 also reported that acanthosis nigricans was not a good marker for hyperinsulinemia in overweight children.
Obesity increases the risk of cardiovascular disease in adults and has been strongly associated with insulin resistance. 40, 41 Several studies consistently demonstrated that hyperinsulinemia and insulin resistance are strong predictors of type 2 diabetes 42, 43 and are associated with adverse lipid and lipoprotein levels 44 and prevalent atherosclerosis. 45 There is evidence that obesity in childhood increases the risk of onset of the metabolic syndrome in adulthood. 46 In our cohort, patients with decreased insulin sensitivity had a higher prevalence of PCO and obesity complications, including hypertension, fatty liver, pseudotumor cerebri, and sleep apnea. Surprisingly, the insulin resistance indexes were not significantly correlated with the blood lipid profile, except for triglyceride levels. Insulin plays a central role in determining triglyceride clearance from the blood by activation of lipoprotein lipase and triglyceride output via its effects on the synthesis and secretion of very low-density lipoprotein (VLDL) by the liver. 47 Researchers suggest that triglyceride-rich lipoproteins accumulate in the circulation in the insulin-resistant state, owing to the decreased activity of lipoprotein lipase, increased lipolysis in adipose tissue, 48 and increased output of VLDL particles from the liver. 47 The delay in plasma triglyceride clearance allows for cholesterol esters in HDL to be exchanged for triglyceride, which results
Insulin resistance in obese children and adolescents S Shalitin et al in HDL lipolysis by hepatic triglyceride lipase and subsequent HDL degradation. 49 This study has several limitations. First, the adiposity was measured in terms of BMI, and there is much data about the link between visceral obesity, insulin resistance, type 2 diabetes, and cardiovascular risk. Nevertheless, although BMI does not reflect body fatness exclusively, it can serve as an equally good predictor of risk variables, such as high blood pressure and glucose intolerance, to any other measure of body fat. 50 Second, we did not determine the HOMA-IR, GF/IF, QUICKI or HOMA-%B indexes in healthy lean young subjects. We assumed that insulin resistance and sensitivity indexes are similar among the Caucasian population, and therefore we relied mainly on adult reference standards from published data. 23, 51, 52 In summary, given the peak incidence of type 2 diabetes in adolescence and the known decrease in insulin sensitivity during puberty, the assessment of insulin sensitivity in obese children and adolescents has clinical relevance for identifying subjects at high risk of type 2 diabetes and cardiovascular disease. As neither fasting blood glucose nor insulin levels nor HOMA-IR or HOMA-%B indexes were effective in screening for IGT, an OGTT is currently required in all high-risk subjects, and there is need for the development of other markers that are more broadly applicable outside the sophisticated clinical setting.
The factors that make some individuals more likely to progress to type 2 diabetes are not well understood. Longitudinal studies are warranted to identify the metabolic precursors and the natural history of the development of type 2 diabetes.
Improving insulin resistance may be crucial to the prevention of both type 2 diabetes and premature cardiovascular disease in the young population at risk.
